Operationalizing patient-centered cancer care in low- and middle-income countries

Cell Rep Med. 2024 May 21;5(5):101517. doi: 10.1016/j.xcrm.2024.101517.

Abstract

Rising cancer survival rates in low- and middle-income countries (LMICs) necessitate a paradigm shift to holistic, patient-driven care, focusing on meaningful outcomes aligned with individual values. Data, co-creation, continuous improvement, and collaboration are key. By prioritizing patient-defined metrics and patient empowerment, LMICs can transform cancer care, fostering sustained well-being beyond disease control.

Publication types

  • Review

MeSH terms

  • Developing Countries*
  • Humans
  • Income
  • Neoplasms* / therapy
  • Patient-Centered Care*